Postnatal Serum Insulin-Like Growth Factor 1 and Retinopathy of Prematurity in Latin-American Infants

Investigator: Alejandra G. De Alba Campomanes, MD, MPH
Sponsor: Bayer HealthCare Pharmaceuticals, Inc

Location(s): United States


In 2012, Bayer HealthCare launched the Global Ophthalmology Awards Program (GOAP) with the aim of advancing the scientific understanding and clinical management of retinal ophthalmic disorders. Through grants supporting research and training in ophthalmology, the program seeks to provide opportunities for treatment improvement and to encourage ophthalmologists to further develop their skills in the management of retinal disorders.